Tonghua Golden-Horse Pharmaceutical Industry's (SHE:000766) stock fluctuated more than 20% for two straight trading sessions on June 29 and 30, according to a Wednesday filing with the Shenzhen bourse.
The stock movement coincided with the approval of its anveracrine succinate tablets for mild to moderata Alzheimer's, the filing said.
Shares closed 2% lower on Wednesday.